ライフサイエンスコーパス: renal stone

1 pelvic kidney, a calyceal diverticulum, or a renal stone.

2 innate immunity, as well as protect against renal stones.

3 while helping detect clinically significant renal stones.

4 ortment of minimally invasive tools to treat renal stones.

5 (CaOx) being the predominant constituent of renal stones.

6 fy the chemical composition of the extracted renal stones.

7 c disease is common, and severe disease with renal stones and metabolic bone disease arises less freq

8 c and without classic complications, such as renal stones and osteoporosis, at diagnosis.

9 resence of renal medullary hyperattenuation, renal stones, and bladder urine attenuation levels were

10 festations include urinary tract infections, renal stones, and hematuria.

11 tection against urinary tract infections and renal stones, and possibly as a systemic antioxidant.

12 stuartii in a patient with a history of UTI, renal stones, and stent placement.

13 women aged 20-92 years to determine whether renal stones are associated with 1) food or water exposu

14 deposits in kidneys of patients with calcium renal stones, arise in unique anatomical regions of the

15 alence of renal stones, nor do they identify renal stones as a risk factor for low bone mineral densi

16 With DECT, renal stone attenuation at low and high kVp was attained

17 me, lung vessel, automated bone removal, and renal stone characterization images) and virtual monoene

18 l history included previous intervention for renal stones, cholecystectomy, and cardiovascular and re

19 nce of four DECT technologies in determining renal stone composition at standard- and low-dose acquis

20 sing techniques improves characterization of renal stone composition beyond that achieved with single

21 nergy CT (DECT) technologies for determining renal stone composition.

22 Women with renal stones consumed almost 250 mg/day less dietary cal

23 performed at a mean age of 55 years and that renal stones developed at 64 years, cardiac-valve involv

24 his population-based study examined reported renal stone diagnosis in 1,309 women aged 20-92 years to

25 cium-based calculi account for around 75% of renal stone disease and the incidence of these calculi i

26 cute calcium oxalate (CaOx) nephropathy, and renal stone disease can lead to inflammation and subsequ

27 The detection of monogenic causes of renal stone disease has been made more feasible by the u

28 Renal stone disease is a frequent condition, causing a h

29 m nephrolithiasis is the most common form of renal stone disease, with calcium oxalate (CaOx) being t

30 mon kidney-based disorders: hypertension and renal stone disease.

31 is crucial for understanding and controlling renal stone disease.

32 s an important factor in the pathogenesis of renal stone disease.

33 e treatment and prevention of recurrence) of renal stone disease.

34 te kidney injury, chronic kidney disease and renal stone disease.

35 xible ureteroscopes have allowed us to treat renal stones endoscopically through natural orifices.

36 racterization of renal calculi, with ex vivo renal stone evaluation using Fourier transform infrared

37 pigment deposits lead to joint destruction, renal stone formation and cardiac valvulopathy respectiv

38 Increased risk of renal stone formation during space flight has been linke

39 diagnosis suggest that genetic components of renal stone formation need further study.

40 is contextual change in our understanding of renal stone formation opens fundamentally new avenues of

41 Renal stone formation was not associated with community

42 Cd(2+)-induced hypercalciuria and resultant renal stone formation.

43 eabsorption of citrate is closely related to renal stone formation.

44 lly identified genes that may be involved in renal stone formation.

45 tentially play a role in the pathogenesis of renal stone formation.

46 Urinary calcium excretion in most renal stone formers is more dependent on the dietary aci

47 ay represent precursors of calcification and renal stones in humans.

48 agent clinically approved for prevention of renal stones in patients with cysteinuria, significantly

49 Little is known about the epidemiology of renal stones, in spite of the relative frequency of this

50 ished data indicate that about half of small renal stones left in place at the time that larger stone

51 m is associated with a greater prevalence of renal stones, nor do they identify renal stones as a ris

52 demarcation of abscess, characterization of renal stones or reduction of artifacts.

53 02), younger age (P < .001), and presence of renal stones (P = .047).

54 Results indicated a renal stone prevalence of 3.4%.

55 An increase in mean CTDIvol was observed for renal stone protocols (26.2%) and thoracic or lumbar spi

56 Three to five renal stones (range, 2.0-4.0 mm) were randomly placed in

57 eatures for liver lesions, lung nodules, and renal stones, respectively (P < .002 for all comparisons

58 eatures for liver lesions, lung nodules, and renal stones, respectively (P < .002 for all comparisons

59 eatures for liver lesions, lung nodules, and renal stones, respectively (P < .002 for all comparisons

60 The evolution of percutaneous renal stone surgery has recently seen an increasing numb

61 our study, the mean attenuation ratio of the renal stone was 1.57 +/- 0.25.

62 ng nucleation of the most common crystals in renal stones, which are composed of calcium oxalate and

63 0 to 30 mAs resulted in similar detection of renal stones while reducing patient radiation exposure b

64 note, the measured size of lung nodules and renal stones with MBIR was significantly different than